JP2023521634A5 - - Google Patents
Info
- Publication number
- JP2023521634A5 JP2023521634A5 JP2022559967A JP2022559967A JP2023521634A5 JP 2023521634 A5 JP2023521634 A5 JP 2023521634A5 JP 2022559967 A JP2022559967 A JP 2022559967A JP 2022559967 A JP2022559967 A JP 2022559967A JP 2023521634 A5 JP2023521634 A5 JP 2023521634A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutically acceptable
- acceptable salt
- composition
- hydroxychloroquine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901030A AU2020901030A0 (en) | 2020-04-02 | A method of treatment | |
| AU2020901030 | 2020-04-02 | ||
| AU2020902432A AU2020902432A0 (en) | 2020-07-14 | A method of treatment | |
| AU2020902432 | 2020-07-14 | ||
| AU2020903985 | 2020-11-02 | ||
| AU2020903985A AU2020903985A0 (en) | 2020-11-02 | A method of treatment | |
| AU2020904264 | 2020-11-18 | ||
| AU2020904264A AU2020904264A0 (en) | 2020-11-18 | A method of treatment | |
| AU2021900241A AU2021900241A0 (en) | 2021-02-03 | A method of treatment | |
| AU2021900241 | 2021-02-03 | ||
| AU2021900324 | 2021-02-10 | ||
| AU2021900324A AU2021900324A0 (en) | 2021-02-10 | A method of treatment | |
| PCT/AU2021/050226 WO2021195691A1 (en) | 2020-04-02 | 2021-03-15 | Methods and compositions for treating or preventing an inflammatory condition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521634A JP2023521634A (ja) | 2023-05-25 |
| JP2023521634A5 true JP2023521634A5 (https=) | 2024-03-18 |
Family
ID=77926837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559967A Pending JP2023521634A (ja) | 2020-04-02 | 2021-03-15 | 炎症状態を処置または予防するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230128114A1 (https=) |
| EP (1) | EP4125835A4 (https=) |
| JP (1) | JP2023521634A (https=) |
| AU (1) | AU2021250462A1 (https=) |
| CA (1) | CA3169702A1 (https=) |
| CO (1) | CO2022015048A2 (https=) |
| IL (1) | IL296943A (https=) |
| WO (1) | WO2021195691A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240325312A1 (en) * | 2021-07-15 | 2024-10-03 | Incannex Healthcare Limited | Composition comprising cannabidiol and hydroxychloroquine in a fixed dose combination capsule |
| WO2024025525A1 (en) * | 2022-07-27 | 2024-02-01 | Medterra Pharma Llc | Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453431A (en) * | 1993-10-29 | 1995-09-26 | Gilman; Andrew L. | Use of hydroxychloroquine for treatment of graft-versus-host disease |
| GB9807639D0 (en) * | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
| US20040242632A1 (en) * | 2001-11-09 | 2004-12-02 | Charous B. Lauren | Method for treating inflammatory bowel disease |
| US20200009077A1 (en) * | 2018-07-03 | 2020-01-09 | TRUETIVA, Inc. | Compositions for treating dermatological diseases |
| CN115916336A (zh) * | 2020-02-19 | 2023-04-04 | 施里玛·麦钱特 | 大麻二酚的组合物和治疗用途 |
-
2021
- 2021-03-15 US US17/907,322 patent/US20230128114A1/en active Pending
- 2021-03-15 AU AU2021250462A patent/AU2021250462A1/en active Pending
- 2021-03-15 IL IL296943A patent/IL296943A/en unknown
- 2021-03-15 JP JP2022559967A patent/JP2023521634A/ja active Pending
- 2021-03-15 EP EP21781628.9A patent/EP4125835A4/en active Pending
- 2021-03-15 WO PCT/AU2021/050226 patent/WO2021195691A1/en not_active Ceased
- 2021-03-15 CA CA3169702A patent/CA3169702A1/en active Pending
-
2022
- 2022-10-21 CO CONC2022/0015048A patent/CO2022015048A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004507444A5 (https=) | ||
| JP2023521634A5 (https=) | ||
| HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
| JP2012503668A5 (https=) | ||
| US20020106342A1 (en) | Methods for treating atopic disorders | |
| JP2023520323A5 (https=) | ||
| JP2010526840A5 (https=) | ||
| CA2733294A1 (en) | Pharmaceutical combination of a tiotropium salt and ciclesonide | |
| JP2010515682A5 (https=) | ||
| Bermejo-Martin et al. | Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains | |
| JP2005523263A5 (https=) | ||
| CN115666572A (zh) | 用于预防或治疗流行性rna病毒传染病的药物组合物 | |
| Soni et al. | Influenza, SARS-CoV-2, and their impact on chronic lung diseases and fibrosis: exploring therapeutic options | |
| JP2022527401A5 (https=) | ||
| JP2020516689A5 (https=) | ||
| JP2009518415A5 (https=) | ||
| JP2023532170A5 (https=) | ||
| JP2005537282A5 (https=) | ||
| Szczeklik et al. | Asthma improved by aspirin-like drugs | |
| JP2013518061A5 (https=) | ||
| US12383546B2 (en) | Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquine | |
| JP2024543259A5 (https=) | ||
| Cho et al. | Lateral position prevents respiratory occlusion during surgical procedure under general anesthesia in the patient of huge anterior mediastinal lymphoblastic lymphoma | |
| CN106265684A (zh) | 乙酰羽扇豆醇酯的应用 | |
| Kut et al. | A 55-year-old man with cough and Hematochezia |